back to Meetings page
- IMMPACT-VII
- June 9-10, 2006
- Ritz Carlton Pentagon City
- Arlington, Virginia
Co-chairs:- Dennis C. Turk, PhD (University of Washington)
- Robert H. Dworkin, PhD (University of Rochester)
- Academia Participants
- Ralf Baron, MD (University of Kiel)
- Nicholas Bellamy, MD (University of Queensland)
- Charles S. Cleeland, PhD (MD Anderson Cancer Center)
- Susan Ellenberg, PhD (University of Pennsylvania)
- John T. Farrar, MD (University of Pennsylvania)
- Jacqueline A. French, MD (University of Pennsylvania)
- Ian Gilron, MD (Queen's University)
- Alejandro R. Jadad, MD, DPhil (University of Toronto)
- Nathaniel P. Katz, MD (Tufts University Medical School)
- Michael McDermott, PhD (University of Rochester)
- Patrick McGrath, PhD (Dalhousie University)
- Henry J. McQuay, MD (University of Oxford)
- Cristina Sampaio, MD, PhD (Faculdade de Medicina de Lisboa)
- David M. Simpson, MD (Mt. Sinai School of Medicine)
- Gerold Stucki, MD (University of Munich)
- Michael E. Thase, MD (University of Pittsburgh)
- Government Participants
- Laurie B. Burke, RPh, MPH (US Food and Drug Administration)
- Ann Costello, DMD, PhD (US Food and Drug Administration)
- Sharon Hertz, MD (US Food and Drug Administration)
- Robert D. Kerns, PhD (Veterans Administration and Yale University)
- Thomas Permutt, PhD (US Food and Drug Administration)
- Linda Porter, PhD (National Institutes of Neurological Disorders and Stroke)
- Bob A. Rappaport, MD (US Food and Drug Administration)
- Bryce Reeve, PhD (National Cancer Institute)
- James Witter, MD, PhD (US Food and Drug Administration)
- Patient Representative
- Penney Cowan (American Chronic Pain Association)
- Industry Participants
- Amy S. Chappell, MD (Eli Lilly & Company)
- Kevin Chartier, PhD (Pfizer)
- Rozalina Dimitrova, MD, MPH (Allergan, Inc.)
- Gary W. Jay, MD (Schwarz Biosciences)
- Jarkko Kalliomaki, MD, PhD (AstraZeneca)
- Donald C. Manning, MD, PhD (Celgene Corporation)
- Avind Narayana, MD (Cephalon, Inc.)
- Steven Quessy, PhD (GlaxoSmithKline)
- Christine Rauschkolb, MD, PhD (Johnson & Johnson)
- Thomas Rhodes, MSPH (Merck & Company)
- Joseph W. Stauffer, DO (Alpharma)
- Jeffrey Tobias, MD (NeurogesX, Inc.)
- Richard E. White, PhD (Endo Pharmaceuticals)